S-nitroso-N-acetylpenicillamine (SNAP) during hemorrhagic shock improves mortality as a result of recovery from vascular hyporeactivity

Anesthesia and Analgesia

Volumn 90, Issue 2, 2000, Pages 362-368

  Sato, Shigehito ^a   Suzuki, Akira ^a   Nakajima, Yoshiki ^a   Iwamoto, Tatsuaki ^a   Bito, Hiromichi ^a   Miyabe, Masayuki ^b  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NORADRENALIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; DOG; HEART OUTPUT; HEMODYNAMICS; HEMORRHAGIC SHOCK; MEAN ARTERIAL PRESSURE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 0033951722     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200002000-00023     Document Type: Article

References (27)

1. Quinn AC, Petrol AJ, Vallance P. Nitric oxide: an endogenous gas. Br J Anaesth 1995;74:443-51.
2. Ayuse T, Brienza N, Revelly JP, et al. Role of nitric oxide in porcine liver circulation under normal and endotoxemic conditions. J Appl Physiol 1995;78:1319-29.
3. Landin L, Lorente JA, Renes E, et al. Inhibition of nitric oxide synthesis improves the vasoconstrictive effect of noradrenaline in sepsis. Chest 1994;106:250-6.
4. Zingarelli B, Squadrito F, Altavilla D, et al. Evidence for a role of nitric oxide in hypovolemic hemorrhagic shock. J Cardiovasc Pharmacol 1992;19:982-6.
5. Brown IP, Williams RL, McKirman MD, et al. Nitric oxide synthesis inhibition does not improve the hemodynamic response to hemorrhagic shock in dehydrated conscious swine. Shock 1995;3:292-8.
6. Harbrecht BG, Wu B, Watkins SC, et al. Inhibition of nitric oxide synthase during hemorrhagic shock increase hepatic injury. Shock 1995;4:332-7.
7. Klabunde RE, Slayton KJ, Ritger RC. NG-methyl-L-arginine restores arterial pressure in hemorrhaged rats. Circ Shock 1993; 40:47-52.
8. Yao YM, Bahrami S, Leichtfried G, et al. Significance of NO in hemorrhage-induced hemodynamic alterations, organ injury, and mortality in rats. Am J Physiol 1996;270:H1616-23
9. Sato S, Miyabe M, Saito S, Yamaguchi H. Nitric oxide in the brain during short period of hemorrhagic shock in the rabbit. Shock 1997;8:136-40.
10. Symington PA, Ma XL, Lefer AM. Protective actions of S-nitroso-N-acetyllpenicillamine (SNAP) in a rat model of hemorrhagic shock. Meth Find Exp Clin Phramacol 1992;14:789-97.
11. Christofer TA, Ma H-L, Lefer AM. Beneficial actions of S-Nitroso-N-acetylpenicillamine, a nitric oxide donor, in murine traumatic shock. Shock 1994;1:19-24.
12. Kurose I, Wolf R, Grisham MB, Granger DN. Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ Res 1994;74:376-82.
13. Carey C, Siegfried MR, Ma-XL, Weyrich AS. Antishock and endothelial protective actions of a NO donor in mesenteric ischemia and reperfusion. Circ Shock 1992;38:209-16.
14. Green LC, Wagner DA, Glogowski J, et al. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem 1982;126:131-8.
15. Aoki N, Johnson G III, Lefer AM. Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock. Am J Physiol 1990;258:G275-81
16. Daughters K, Waxman K, Nguyen H. Increasing nitric oxide improves survival in experimental hemorrhagic shock. Resuscitation 1996;31:141-4.
17. Lefer AM, Tsao PS, Lefer DJ, Ma XL. Role of endothelial dysfunction in the pathogenesis of reperfusion injury myocardial ischemia. FASEB J 1991;5:2029-34.
18. Kubes P, Granger DN. Nitric oxide modulates microvascular permeability. Am J Physiol 1992;262:H611-5.
19. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-5.
20. Ignarro LJ, Lippton H, Edwards JC, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981;218:739-49.
21. Shaffer JE, Han BJ, Chern WH, Lee FW. Lack of tolerance to a 24 hour infusion of S-nitroso-N-acetylpenicillamine (SNAP) in conscious rabbits. J Pharmacol Exp Ther 1992;260:286-93.
22. Bauer JA, Fung HL. Differential hemodynamic effects and tolerance properties of nitroglycerine and an S-nitrosothiol in experimental heart failure. J Pharmacol Exp Ther 1991;256:249-56.
23. Ma XL, Tsao PS, Viehman GE, Lefer AM. Neutrophil mediated vasoconstriction and endothelial dysfunction in low flow perfusion reperfused cat coronary artery. Circ Res 1991;69:95-106.
24. Thiemermenn C, Szabo C, Mitchel JA, Vane JR. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Acad Sci USA 1993;90:267-71.
25. Colasanti M, Persichini T, Menegazzi Met, al. Induction of nitric oxide synthase mRNA expression: suppression by exogenous nitric oxide. J Biol Chem 1995;270:26731-3.
26. Kelly E, Shah NS, Morgan NN, et al. Physiological and molecular characterization of the role of nitric oxide in hemorrhagic shock: evidence that type II nitric oxide synthase does not regulate vascular decompensation. Shock 1997;7:157-63.
27. Vromen A, Szabo C, Southan GJ, Salzman AL. Effects of S-isopropyl isothiourea, a potent inhibitor of nitric oxide synthase, in severe hemorrhagic shock. J Appl Physiol 1996;81: 707-15.